MedTrace Logo

The Gut Microbiome in Adult Multiple Sclerosis

NCT04929145 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 152

Last updated 2021-07-23

No results posted yet for this study

Summary

This study aims to assess the following research questions:

1. Map and benchmark the gut microbiome of patients with RRMS, and PPMS versus matched healthy controls
2. Determine whether RRMS or PPMS have a unique bias for a gut microbiome classification recently characterized.
3. Search for relationship with inflammation, amino acid plasma levels, heart rate variability (vagus nerve tone) and hair cortisol as a biological marker of chronic stress
4. Determine whether the gut microbiome is different in MS patients during a relapse.
5. Determine whether the gut microbiome remains stable after 3 months

Conditions

Sponsors & Collaborators

  • National MS Center Melsbroek

    lead OTHER

Principal Investigators

  • Marie D'hooghe, M.D. · National MS Center Melsbroek

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-02
Primary Completion
2019-09-16
Completion
2020-04-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04929145 on ClinicalTrials.gov